CAMBRIDGE, Mass., May 9 /PRNewswire-FirstCall/ -- Millennium
Pharmaceuticals, Inc. (Nasdaq: MLNM) announced today that its annual
meeting of stockholders will be webcast live and may be accessed by
visiting the Investors section of the Company's website,
http://www.millennium.com .
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
Millennium senior management will provide an overview of the Company.
The presentation will be delivered at 10:00 a.m. ET on Thursday, May 10,
2007 from the Royal Sonesta Hotel in Cambridge, Mass. The presentation will
be archived for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company
based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a
novel cancer product, and has a robust clinical development pipeline of
product candidates. The Company's research, development and
commercialization activities are focused in oncology and inflammatory
diseases. By applying its knowledge of the human genome, understanding of
disease mechanisms and industrialized drug discovery platform, Millennium
is developing an exciting pipeline of innovative product candidates. The
Company's website is http://www.millennium.com .
Editors' Note: This press release is also available under the Media
section of the Company's website at: http://www.millennium.com .
Contact:
Kyle Kuvalanka
(617) 761-4734
SOURCE Millennium Pharmaceuticals, Inc.
 back to top
Related links:
http://www.millennium.com
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
http://www.prnewswire.com/comp/114562.html/
CONTACT:
Kyle Kuvalanka of Millennium Pharmaceuticals,
Inc., +1-617-761-4734
|
